Saturday, Nov 17, 2018
engineered enzymes for better healthcare

高胱氨酸尿(HCY) 是由阻碍高胱氨酸代谢的酶缺失所导致其发病率大约为 1/68,000爱尔兰)。主要的临床症状包括光学错位影响 80% 15 岁以下HCY 患者)、精神发育迟缓、骨质疏松和血栓栓塞导致 50% 20岁以下HCY 患者死亡75% 30 岁以下HCY 患者死亡。通过早期检测、严格的饮食控制和补充维生素,生长和发育就可恢复正常。

产品信息

 

amino-acid-disorders-product氨基酸代谢疾病

PKU            苯酮尿症

MSUD          枫糖尿症

HCY            高胱氨酸尿症

TYR-I          酪胺酸血症第一型

 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...